CSL settles plasma price-fixing case for $64M October 10, 2013 By Brad Perriello Leave a Comment CSL Ltd. (ASX:CSL) said it agreed to pay $64 million to settle multi-district litigation accusing it of taking part in a price-fixing scheme for plasma therapy.